Back to funds

Foresite Capital Management V, LLC

Updated 6 days ago

Managed by Foresite Capital Management V, Llc • Latest filing Q3 2026

Portfolio value
$289.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$164.4M
Q1 2026$271M
Q2 2026$362.2M
Q3 2026$289.1M

Top holdings

9 positions as of Q3 2026

View filing
C

CG Oncology, Inc.

Value
$76.5M
Shares
1.08M
% Port
26.45%
L

Latigo Biotherapeutics, Inc.

Value
$59.5M
Shares
3.56M
% Port
20.58%
A

ALUMIS INC.

Value
$43.6M
Shares
5.90M
% Port
15.07%
H

Hims & Hers Health, Inc.

Value
$26.3M
Shares
883.8K
% Port
9.11%
I

Disc Medicine, Inc.

Value
$24.5M
Shares
374.1K
% Port
8.47%
P

Pharvaris N.V.

Value
$21.1M
Shares
664.1K
% Port
7.29%
O

Odyssey Therapeutics, Inc.

Value
$16.2M
Shares
729.6K
% Port
5.61%
N

Nurix Therapeutics, Inc.

Value
$10.9M
Shares
458.7K
% Port
3.76%
E

Eikon Therapeutics, Inc.

Value
$10.6M
Shares
1.32M
% Port
3.67%

Explore